Register a homeopathic medicine

AI Summary

This regulatory guidance issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA) outlines the compliance requirements for marketing homeopathic medicinal products via two distinct pathways: the Simplified Registration Scheme and the National Rules Scheme. Operating under Regulation 8 of the Human Medicines Regulations, the Simplified Registration Scheme is restricted to products for oral or external use that are diluted by at least 1 in 10,000, ensuring safety while prohibiting any therapeutic claims. In contrast, the National Rules Scheme allows for the treatment of minor conditions based on UK homeopathic traditions without dilution limits, provided safety and quality data are supplied. Key regulatory considerations include adherence to the Windsor Framework, which requires 'UK Only' labeling for National Rules products, and compliance with the British or European Pharmacopoeia. To fulfill required actions, applicants must submit documentation through the MHRA electronic portal using eCTD or NeeS formats. Manufacturers are responsible for providing comprehensive data on manufacturing procedures, stability testing, and labeling literature. Failure to submit accurate data or utilize the correct electronic application forms will prevent application validation. The MHRA estimates a 210-day evaluation period for valid submissions, and companies must use the official fee calculator to ensure correct payment. While no specific company violations are noted in this general guidance, strict adherence to these submission and labeling protocols is mandatory for all UK homeopathic suppliers.